PRK (October 2024)/ CME GLOBEX
PRK2024-07-26 7:43:25 PM | Chg. +0.5000 | Bid11:50:04 PM | Ask11:50:04 PM | Open | High | Low | Previous Close |
---|---|---|---|---|---|---|---|
92.4500USD | +0.54% | 87.5250 | 96.4750 | 92.4500 | 92.4500 | 92.4500 | 91.9500 |
GlobeNewswire
07-22
Park National Corporation reports financial results for second quarter and first half of 2024
GlobeNewswire
05-21
Park National Corporation welcomes Kelly Gratz and Karen Morrison to Board of Directors
GlobeNewswire
04-11
First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS...
GlobeNewswire
01-19
Regency Centers Announces Tax Information for Regency Centers and Urstadt Biddle Properties 2023 Dis...
GlobeNewswire
2023-10-23
Park National Corporation reports financial results for third quarter and first nine months of 2023
GlobeNewswire
2022-03-28
EVO VISIAN® ICL NOW AVAILABLE IN THE US: PARKHURST NUVISION OF SAN ANTONIO TEXAS AMONG FIRST IN THE ...
GlobeNewswire
2021-12-21
Park National Corporation welcomes D. Byrd Miller III to Board of Directors
GlobeNewswire
2021-11-15
Kiora Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
2021-11-08
EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s Sharpened Clinical Development St...
GlobeNewswire
2021-10-29
Physician Growth Partners Advises Griffey Eye Care & Their Affiliated Entities in a Partnership With...
GlobeNewswire
2021-10-26
EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes A...
GlobeNewswire
2021-10-25
Park National Corporation reports financial results for third quarter and first nine months of 2021
GlobeNewswire
2021-10-04
Agrify Acquires Precision Extraction Solutions and Cascade Sciences, Two of the Leading Cannabis and...
GlobeNewswire
2021-09-09
EyeGate to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire
2021-09-08
EyeGate Pharma Completes Target Enrollment in Phase 2 Proof-of-Concept Study to Evaluate PP-001 for ...
GlobeNewswire
2021-07-30
Park National Corporation welcomes Dr. Frederic Bertley to board of directors
GlobeNewswire
2021-07-26
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Execu...
GlobeNewswire
2021-07-26
Park National Corporation reports financial results for second quarter and first half of 2021
GlobeNewswire
2021-04-26
Park National Corporation leader Daniel DeLawder announces retirement after 50 years of service